α-黑色素细胞刺激激素通过黑色皮质素5受体缓解病态心脏重塑
Anni Suominen1,2, Guillem Saldo Rubio1, Saku Ruohonen1
1Research Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
EMBO reports
|March 7, 2024
概括
阿尔法-黑色素细胞刺激激素 (α-MSH) 通过激活心肌细胞中的黑色素5受体 (MC5-R) 来保护心脏免受病理重塑. 这一发现表明α-MSH类似物可以治疗心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 阿尔法-黑色素细胞刺激激素 (α-MSH) 是通过黑色素皮质受体 (MC-R) 的生理功能的关键调节者.
- 之前,α-MSH及其受体在心脏生理学和病理学的特定作用未被描述.
研究的目的:
- 调查α-MSH在病态心脏重塑中的参与.
- 为了确定特定的MC-R亚型介导α-MSH的潜在心脏影响.
主要方法:
- 利用鼠标模型的横向大动脉收缩 (TAC) 诱导心脏重塑.
- 给了稳定的α-MSH模拟物,并评估了心脏功能和缩.
- 使用心肌细胞进行了体外研究,以检查MC5-R.的作用.
- 在体外和体内研究了MC5-R沉默和药理活性的影响.
主要成果:
- 在小鼠心脏中检测到α-MSH表达,在TAC后下降.
- 用α-MSH类比剂减轻了TAC诱导的心脏缩和心功能障碍.
- 在心肌细胞中的MC5-R被确定为α-MSH抗缩作用的调解者.
- 沉默MC5-R加剧了心脏缩和纤维化,而它的激活改善了心脏功能和减少了纤维化.
结论:
- α-MSH在心脏表达,并对病态心脏重塑产生保护作用.
- α-MSH的抗重塑作用是通过心肌细胞中的MC5-R激活介导的.
- 包括最近批准的α-MSH类似物在内的MC5-R激动剂,代表了心力衰竭的潜在治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K